APA (7th ed.) Citation

Kim, S. G., Kim, D. M., Woo, J., Jang, H. C., Chung, C. H., Ko, K. S., . . . Choi, D. S. Efficacy and safety of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 24-weeks: A multicenter, randomized, double-blind, parallel-group, placebo controlled trial. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Kim, Sin Gon, et al. Efficacy and Safety of Lobeglitazone Monotherapy in Patients with Type 2 Diabetes Mellitus over 24-weeks: A Multicenter, Randomized, Double-blind, Parallel-group, Placebo Controlled Trial. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Kim, Sin Gon, et al. Efficacy and Safety of Lobeglitazone Monotherapy in Patients with Type 2 Diabetes Mellitus over 24-weeks: A Multicenter, Randomized, Double-blind, Parallel-group, Placebo Controlled Trial. Public Library of Science (PLoS).